文献速递腹部MR

钆塞酸二钠MR成像的变异系数:与慢性乙型肝炎患者早期肝细胞癌存在的相关性

Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
PubMed 文献 · Eur J Radiol · 2018-02-27

本研究纳入104例患者分为对照组、无肝硬化慢性乙型肝炎组、伴肝硬化慢性乙型肝炎组及伴肝硬化且合并肝细胞癌组,测量钆塞酸二钠增强MR肝胆期肝实质信号强度的变异系数。结果显示变异系数与肝细胞癌存在相关,诊断肝细胞癌的AUC为0.788,与甲胎蛋白(AUC 0.766)诊断性能相当。

要点

  • 钆塞酸二钠增强MR肝胆期肝实质变异系数在合并肝细胞癌的慢性乙型肝炎肝硬化患者中升高。
  • 变异系数诊断肝细胞癌的AUC为0.788,敏感度84.2%、特异度63.6%(阈值>4.75)。
  • 变异系数诊断肝细胞癌的AUC与甲胎蛋白(0.766)相近。

核心结论

  • 钆塞酸二钠MR成像上肝纤维化的变异系数值可能与慢性乙型肝炎患者肝细胞癌的存在相关,诊断性能与甲胎蛋白分析相当。

研究设计与样本

  • 研究纳入104例有或无慢性乙型肝炎的患者,分为对照组、无肝硬化的慢性乙型肝炎组(I组)、伴肝硬化的慢性乙型肝炎组(II组)、伴肝硬化且合并肝细胞癌的慢性乙型肝炎组(III组),使用钆塞酸二钠增强MR成像测量肝实质信号强度变异系数图,采用方差分析进行组间比较,并采用受试者工作特征曲线评估变异系数图与甲胎蛋白诊断肝细胞癌的性能。

关键影像表现/征象

  • 在钆塞酸二钠增强T1加权成像肝胆期,对照组、I组、II组和III组的平均变异系数值分别为3.9±0.99、3.97±1.09、5.58±2.05和6.80±2.34(P=0.000)。

诊断标准与关键数值

  • 变异系数值预测肝细胞癌的ROC分析中,钆塞酸二钠MR成像的AUC为0.788(95%CI:0.697-0.862)。
  • 在变异系数阈值>4.75时,敏感度为84.2%,特异度为63.6%。
  • 甲胎蛋白诊断肝细胞癌的AUC为0.766。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To study whether the measurement of hepatic fibrosis on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) magnetic resonance (MR) imaging using the coefficient of variation (CV) might be correlated with the presence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB).

MATERIALS AND METHODS: This study included 104 patients with and without CHB, who were divided into 4 groups: control group, CHB without liver cirrhosis (LC; Group I), CHB with LC (Group II), and CHB with LC and HCC (Group III). MR images were analyzed to measure the inhomogeneity of signal intensities calculated using the CV map of the liver parenchyma. Intergroup comparisons of CV values were performed using ANOVA. The diagnostic performance of the CV map and alpha-fetoprotein (AFP) for diagnosing HCC was evaluated using the receiver operating characteristic (ROC) curve.

RESULTS: On the hepatobiliary phase of Gd-EOB-DTPA-enhanced T1-weighted imaging, the mean CV values of the control group and Groups I, II, and III were 3.9 ± 0.99, 3.97 ± 1.09, 5.58 ± 2.05, and 6.80 ± 2.34, respectively (P = 0.000). On ROC analysis of the CV value for predicting HCC, the value of the area under the curve (AUC) on Gd-EOB-DTPA MR imaging was 0.788 (95% CI: 0.697-0.862). The sensitivity and specificity were 84.2% and 63.6%, respectively, at a CV cutoff value >4.75. The value of AUC determined using AFP was 0.766.

CONCLUSION: The CV value for hepatic fibrosis on Gd-EOB-DTPA MR imaging may be correlated with the presence of HCC in patients with CHB, and shows comparable diagnostic performance to AFP analysis.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Lee JH, Kim YR, Lee GM, et al. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B. Eur J Radiol. 2018. PMID: 29685552. doi:10.1016/j.ejrad.2018.02.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。